Loughborough University, in partnership with the Universities of Birmingham, Leicester, Edinburgh, and Birmingham Community Healthcare Foundation NHS Trust, has been awarded £2.2 million from the NIHR Programme Grants for Applied Research Board to develop a new approach to promoting physical activity in the population called Snacktivity. The programme of research involves five work packages, and this third work package is building on from previous activities.
We are looking at whether hydroxychloroquine prophylaxis can protect healthcare workers from catching COVID-19.
Do you work in a GP surgery, dental surgery or opticians and are interested in taking part?
Recruiting via General Practices in Coventry, Rugby and Warwickshire, starting January 2021; taking expressions of interest now.
Care Companion is a unique online individually tailored resource, designed for informal carers who look after family and friends with long term or life limiting conditions. It has been developed by a team from Warwick Medical School together with a panel of carers to help individuals with caring responsibilities cope with ever-changing physical, emotional and social care needs.
RAPTOR-C19 is a research study to assess the accuracy of different rapid tests for COVID-19 for patients in the community. The question is whether rapid tests, which give results within minutes/hours, are as accurate as standard laboratory tests. Research will take place in GP surgeries or COVID-19 testing sites. Accurate rapid tests mean quicker decisions about patient care and self-isolation and so are key to our efforts to control COVID-19.
As the CRN is able to move away from engaging in only Urgent Public Health and COVID-19 work, studies that have been put on hold during the pandemic will start to re-open and expressions of interest will be welcomed.
If any of the following studies are of interest, please contact your local research facilitator, details on the back page of the on-line version of Participate, available here.
ATTACK (ASPIRIN TO TARGET ARTERIAL EVENTS IN CHRONIC KIDNEY DISEASE)
is a pragmatic multicentre open-label randomised controlled trial to determine whether the addition of low-dose aspirin to usual care reduces the risk of major vascular events in people with chronic kidney disease (CKD) who do not have pre-existing cardiovascular disease (CVD).